Research Program Leaders

More than 300 members, representing 42 University departments, are working together to improve the understanding of cancer and to develop new lifesaving procedures in cancer prevention, diagnosis, and treatment. UPMC Hillman Cancer Center research programs range from basic science programs that examine the molecular basis of cancer development and progression in the laboratory, to translational and clinical programs that implement novel laboratory findings into clinical trials in humans, to population-based programs that focus on cancer prevention, epidemiology, and biobehavioral factors in cancer.

Research Program Leaders

Jeremy N. Rich, MD, MHS, MBA  Interim Director, Deputy Director, UPMC Hillman Cancer Center; Professor of Neurology, University of Pittsburgh School of Medicine
Jan Beumer, PhD Co-Leader, Cancer Therapeutics Program
Dana Bovbjerg, PhD Co-Leader, Biobehavioral Cancer Control Program
Adam Brufsky, MD, PhD Co-Leader, Cancer Therapeutics Program
Ronald Buckanovich, MD, PhD Co-Leader, Cancer Biology Program
Greg Delgoffe, PhD Co-Leader, Cancer Immunology and Immunotherapy Program
Shou-Jiang (SJ) Gao, PhD Co-Leader, Cancer Virology Program
Haitao Guo, PhD Co-Leader, Cancer Virology Program
James Herman, MD Co-Leader, Cancer Epidemiology and Prevention Program
Steffi Oesterreich, PhD Co-Leader, Cancer Biology Program
Patricia Opresko, PhD Co-Leader, Genome Stability Program
Kathryn Schmitz, PhD, MPH Associate Director for Population Sciences; Co-Leader, Biobehavioral Cancer Control Program
Peter Wipf, PhD Co-Leader, Cancer Therapeutics Program
Jian-Min Yuan, MD, PhD Co-Leader, Cancer Epidemiology and Prevention Program
Hassane Zarour, MD Co-Leader, Cancer Immunology and Immunotherapy Program